Geoffrey A. Swire

Chief Operating Officer presso ALLENA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Geoffrey A.
Swire is currently the COO & Senior Vice President-Corporate Development at Allena Pharmaceuticals, Inc. He previously worked as the Head-Program & Portfolio Management at Genzyme Corp.
and as the Head-Business Development & Alliance Management at Radius Health, Inc. He completed his undergraduate degree at Dartmouth College and his graduate degree at Harvard University.

Posizioni attive di Geoffrey A. Swire

Società	Posizione	Inizio
ALLENA PHARMACEUTICALS, INC.	Chief Operating Officer	10/11/2020

Tutte le posizioni attive di Geoffrey A. Swire

Precedenti posizioni note di Geoffrey A. Swire

Società	Posizione	Fine
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
RADIUS HEALTH, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Geoffrey A. Swire

Formazione di Geoffrey A. Swire

Dartmouth College	Undergraduate Degree
Harvard University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Geoffrey A. Swire

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ALLENA PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology